Provided by Tiger Fintech (Singapore) Pte. Ltd.

Celldex Therapeutics

23.32
+0.40501.77%
Volume:200.01K
Turnover:4.63M
Market Cap:1.55B
PE:-8.64
High:23.50
Open:22.79
Low:22.64
Close:22.91
Loading ...
Jun 12, 2020

Major Issues Report

8-K - Current report
May 06, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 26, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 09, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 08, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 24, 2019

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Jun 21, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jun 21, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 20, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities